Apr 01, 2024 9:00pm EDT ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 15, 2024 8:00am EDT ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
Feb 20, 2024 8:00am EST ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
Feb 14, 2024 8:00am EST ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
Jan 30, 2024 8:00am EST ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
Jan 23, 2024 8:00am EST Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
